share_log

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga ·  Oct 3 20:06

Gainers

  • Theriva Biologics (AMEX:TOVX) shares moved upwards by 53.2% to $1.9 during Thursday's pre-market session. The company's market cap stands at $2.5 million.
  • Conduit Pharmaceuticals (NASDAQ:CDT) shares moved upwards by 22.1% to $0.12. The company's market cap stands at $11.1 million.
  • ENDRA Life Sciences (NASDAQ:NDRA) stock moved upwards by 14.0% to $0.23. The market value of their outstanding shares is at $4.1 million.
  • Syra Health (NASDAQ:SYRA) shares increased by 13.45% to $0.42. The company's market cap stands at $4.1 million.
  • Bio-Path Hldgs (NASDAQ:BPTH) shares rose 12.01% to $0.99. The company's market cap stands at $2.5 million.
  • Redhill Biopharma (NASDAQ:RDHL) shares rose 10.69% to $8.9. The market value of their outstanding shares is at $11.3 million.

Losers

  • Windtree Therapeutics (NASDAQ:WINT) stock decreased by 16.0% to $1.21 during Thursday's pre-market session. The company's market cap stands at $1.9 million.
  • Soligenix (NASDAQ:SNGX) stock fell 14.79% to $4.15. The market value of their outstanding shares is at $9.4 million.
  • Kazia Therapeutics (NASDAQ:KZIA) shares decreased by 11.59% to $0.39. The market value of their outstanding shares is at $11.4 million.
  • ALT5 Sigma (NASDAQ:ALTS) stock declined by 11.3% to $1.58. The market value of their outstanding shares is at $21.3 million.
  • Pasithea Therapeutics (NASDAQ:KTTA) stock decreased by 9.63% to $4.44. The company's market cap stands at $4.6 million.
  • Hims & Hers Health (NYSE:HIMS) stock decreased by 9.08% to $17.23. The company's market cap stands at $3.7 billion.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment